Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04166630 · ClinicalTrials.gov registry record · NA

Diagnosing Intensive Care Unit (ICU) Acquired Weakness

A NA study of ICU Acquired Weakness, sponsored by Emory University.

Completed
Registry status
NA
Development phase
22
Enrollment target
1
Study location

NCT04166630 is a NA study of ICU Acquired Weakness that has completed, run by Emory University. The registered enrollment target is 22 participants, below the 2,109-participant average among 4 other ICU Acquired Weakness trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04166630, a NA study of ICU Acquired Weakness, has completed, sponsored by Emory University.

COMPLETED
Registry status
NA
Development phase
22 participants
Enrollment target
1
Study location

Study Summary

The goal of this study is to develop a non-invasive test to diagnose intensive care unit (ICU) acquired weakness that can be administered to both responsive and non-responsive patients. Study participation will involve the measurement of muscle fatigue during a single 30 minute session. Skeletal muscle will be stimulated with an FDA approved clinical electrical stimulator and accelerations will be passively recorded with an accelerometer.

Conditions Studied

Interventions

  • DEVICE Clinical Electrical Stimulator

Study Locations (1)

Georgia

  • Grady Health System - Atlanta

Trial Details

FieldValue
Enrollment Target 22 participants
Start Date 2021-02-02
Est. Completion 2021-06-11
Phase NA

Sponsor

Emory University

1,208 total trials

What the Registry Record Tells You About NCT04166630

The ClinicalTrials.gov registry entry for NCT04166630 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,109-participant average among 4 other ICU Acquired Weakness trials with a reported enrollment target (99% lower). The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with ICU Acquired Weakness appearing as the primary indexed condition, and to 1 intervention - of which Clinical Electrical Stimulator is the first listed.

NCT04166630 reports 1 study location spanning 1 distinct geographic area - top geographies include Georgia.

Frequently Asked Questions

What is clinical trial NCT04166630 about?

NCT04166630 is a clinical study titled "Diagnosing Intensive Care Unit (ICU) Acquired Weakness". The goal of this study is to develop a non-invasive test to diagnose intensive care unit (ICU) acquired weakness that can be administered to both responsive and non-responsive patients. Study participation will involve the measurement of muscle fatigue during a single 30 minute session. Skeletal mus...

What is the current status of trial NCT04166630?

This trial is currently completed. It is a NA study. The enrollment target is 22 participants. The study started on 2021-02-02. Estimated completion is 2021-06-11.

What conditions does trial NCT04166630 study?

This clinical trial studies the following conditions: ICU Acquired Weakness.

What interventions are being tested in trial NCT04166630?

The interventions under investigation include: Clinical Electrical Stimulator (DEVICE).

Who is sponsoring clinical trial NCT04166630?

This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04166630 being conducted?

This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for ICU Acquired Weakness

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.